Arbutus Biopharma Corp (ABUS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
09-2009 | 06-2009 | 03-2009 | 12-2008 | 09-2008 | |
Sales | 2,983 | 3,240 | 2,320 | 2,569 | 4,057 |
Gross Profit | 2,980 | 3,240 | 2,320 | 2,630 | 4,050 |
Operating Expenses | 5,320 | 5,140 | 4,080 | 3,500 | 6,750 |
Operating Income | -2,337 | -1,900 | -1,760 | -931 | -2,693 |
Other Income | -233 | -30 | 90 | -1,519 | -3,097 |
Pre-tax Income | -2,570 | -1,930 | -1,670 | -2,450 | -5,790 |
Net Income Continuous | -2,577 | -1,931 | -1,672 | -2,569 | -5,794 |
Net Income | $-2,577 | $-1,931 | $-1,672 | $-2,569 | $-5,794 |
EPS Basic Total Ops | -0.05 | -0.03 | -0.03 | -0.06 | -0.11 |
EPS Basic Continuous Ops | -0.05 | -0.03 | -0.03 | -0.06 | -0.11 |
EPS Diluted Total Ops | -0.05 | -0.03 | -0.03 | -0.06 | -0.11 |
EPS Diluted Continuous Ops | -0.05 | -0.03 | -0.03 | -0.06 | -0.11 |
EBITDA(a) | $-1,837 | $-1,430 | $-1,370 | $-491 | $-2,243 |